MedTrace Logo

Effectiveness of Cognitive-Affective Behavior Therapy for the Treatment of Somatization Disorder

NCT00149760 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 88

Last updated 2014-02-20

No results posted yet for this study

Summary

This study will examine the long-term effect of cognitive-affective behavior therapy on the physical symptoms, functioning, and health care utilization of people with somatization disorder.

Conditions

  • Somatization Disorder

Interventions

BEHAVIORAL

Augmented Standard Medical Care

Participants' physicians will receive a letter making specific treatment recommendations for primary care treatment.

BEHAVIORAL

Cognitive-Affective Behavior Therapy

Individually-administered cognitive-behavioral therapy with an emotional focus in addition to augmented standard medical care

Sponsors & Collaborators

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • Rutgers, The State University of New Jersey

    lead OTHER

Principal Investigators

  • Lesley A. Allen, PhD · Department of Psychiatry, Robert Wood Johnson Medical School

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-08-31
Primary Completion
2010-02-28
Completion
2010-02-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00149760 on ClinicalTrials.gov